2 results
Approved WMORecruiting
Primary objective: To assess the efficacy of T-DXd relative to platinum with pemetrexed plus pembrolizumab by assessment of PFS by BICR in participants with unresectable, locally advanced, or metastatic NSCLC harboring HER2 exon 19 or 20 mutations.
Approved WMOCompleted
The primary goal is to increase the available information for the surgeon by providing an extensive lymph node map of the patient. The secondary goal is to compare two magnetic detectors for the further development of a laparoscopic version. The…